Metabolic Supply Group Launches Integrated Lab Testing for Wellness Providers

BRIDGEWATER, N.J., Oct. 19, 2026 /CourierPR/ -- Metabolic Supply Group (MSG) has announced a significant partnership that will streamline lab testing and physician oversight for metabolic and peptide care. The collaboration integrates multiple specimen collection methods, including at-home self-collection, mobile phlebotomy, and walk-in labs, to support providers in delivering patient-centered care.

MSG, a New Jersey-based administrative services organization, connects wellness providers, including med spas, longevity clinics, and telehealth practices, to a vetted national network of licensed compounding pharmacies. With this new partnership, MSG is enhancing its platform to include lab ordering, specimen collection, and results management. This integration will enable providers to work up, treat, and monitor patients in one seamless workflow.

The partnership addresses a critical gap in the market by providing a comprehensive solution for metabolic and peptide therapies. Traditionally, the market has relied on transactional care, characterized by a short intake, a prescription, and minimal baseline testing or follow-up. Providers who wish to offer more thorough care face practical barriers, such as fragmented lab accounts, retail lab pricing that discourages testing, and results arriving outside the tools the practice already uses.

MSG's new service removes these barriers. Providers in the MSG network will gain access to over 40 panels covering hormone, thyroid, metabolic, cardiac and lipid, inflammation, and longevity markers. These panels include testosterone therapy baseline and follow-up kits, mobile phlebotomy, and walk-in labs. Patients can choose from three convenient specimen collection methods: using an at-home self-collection device, booking a mobile phlebotomy visit, or walking into a national lab service center.

All orders and results will be overseen by licensed physicians across all 50 states. Independent physicians will issue orders, review results, and follow up, while practices with their own clinicians can order under their own physicians. This ensures that clinical decisions remain with licensed providers, laboratory testing is performed by independent CLIA-certified laboratories, and physician services are delivered by independent, licensed physicians.

Network-based pricing encourages providers to prioritize thorough patient monitoring, making comprehensive care more accessible and affordable for patients. Results will be integrated into MSG's platform, ensuring that they are visible next to the treatment plan. This seamless integration will help providers to monitor patients over time and make informed decisions.

The partnership will roll out to MSG network providers beginning November 15th, 2026. Providers can learn more at metabolicsupplygroup.com or by contacting their MSG account manager.